A b s t r a c tPathogenicity of methicillin-resistant Staphylococcus aureus (MRSA) is associated with a broad spectrum of virulence factors, amongst which is α-hemolysin. The aim of this study was to investigate the effect of three newly-synthesized chalcones (1,3-Bis-(2-hydroxy-phenyl)-propenone, 3-(3-Hydroxy-phenyl)-1-(2-hydroxy-phenyl)-propenone and 3-(4-Hydroxy-phenyl)-1-(2-hydroxy-phenyl)-propenone) on α-hemolysin production of clinical isolates of MRSA. Subinhibitory concentrations of the tested compounds reduced hemolytic activity of MRSA strains, with almost complete abolishment of hemolysis at concentrations in the range of 1/2-1/4 x MIC (25-12.5 μg/ml). In conclusion, newly-synthesized chalcones tested in this study showed potent inhibitory activity on α-hemolysin production of multiresistant and genetically diverse MRSA strains.
380auditory canal (1) and one laboratory control strain of methicillin-resistant S. aureus ATCC 43300 (KWIK-STIK TM , Microbiologics, USA). Identification of the isolates and methicillin resistance were determined by VITEK 2 test cards GP and AST-P580 (bioMérieux, France) and confirmed by PCR for nuc (Brakstad et al., 1992) and mecA (Bignardi et al., 1996) genes. Genotyping (SCCmec, agr, pvl and spa typing) of MRSA was performed according to previously described protocols (Boye et al., 2007;Lina et al., 2003;Harmsen et al., 2003). The spa types were clustered into spa clonal complexes (CCs) using the algorithm based upon repeat pattern (BURP) with Ridom Staph-Type 1.4 software (http://www.ridom.de). The multiresistance profile of MRSA strains was determined by VITEK 2 test card AST-P580 and further supplemented with disc diffusion test according to CLSI guidelines (CLSI, 2007). Chalcones tested in this study ( Fig. 1) Clinical isolates of MRSA were genetically heterogeneous and expressed multiresistance phenotype (Table I). MRSA strains were classified into SCCmec type I (55.5%), II (5.0%), III (20.0%), IV (10.0%) and V (10.0%) and agr type I (35.0%), II (60.0%) and III (5.0%). Strains belonged to 10 spa types and were clustered into 5 spa CCs, with most frequent CC5 (55.0%) and CC8 (20.0%).Tested chalcones exerted inhibitory activity against MRSA, with the order of potency of chalcones (average MIC ± SD) as following: O-OH (MIC = 37.5 ± 13.2 μg/ml) > M-OH (MIC = 97.5 ± 27.5 μg/ml) > P-OH (MIC = 110.8 ± 21.1 μg/ml). The most significant dosedependent inhibition of hemolysis was observed in MRSA supernatants cultivated with O-OH chalcone (Fig. 2). A 91.6-99.7% reduction of hemolysis was detected in all MRSA strains cultivated with ½ × MIC of O-OH. Hemolytic activity of MRSA strains cultivated with 1/2 × MIC (25.0 µg/ml) and 1/4 × MIC (12.5 µg/ml) of O-OH was in the range of 3.8-8.2% of the positive control (p < 0.001). Mild increase of the hemolytic activity was detected after cultivation with 1/8 × MIC (6.2 µg/ml) up to 19% (p < 0.01), and 1/16 × MIC (3.1 µg/ml) up to 34.6% (p < 0.01). The effect of M-OH 1 .2 µg/ml) did not reduce the hemolytic activity of MRSA (p > 0.0...